TrialAdvances in therapy2015

Effects of Baseline Blood Pressure and Low-Density Lipoprotein Cholesterol on Safety and Efficacy of Canagliflozin in Japanese Patients with Type 2 Diabetes Mellitus.

Nobuya Inagaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.